Rocketvax Revenue

Biotechnology Research • Basel, Basel, Switzerland • 1-10 Employees

Rocketvax revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	$2

Key Contact at Rocketvax

Vladimir Cmiljanovic

Founder, Vice-Chairman And Ceo Of Rocketvax Ag

Company overview

Headquarters	Rittergasse 3, Basel, Switzerland 4051, CH
Phone number	+41615615421
Website	rocketvax.com
NAICS	541714
Keywords	Biotechnology, Vaccine Development, Dna Based Technology, Digital Dna Design Platform, Molecular Technology, Vaccine Vectors
Founded	2020
Employees	1-10
Socials

Rocketvax Email Formats

Rocketvax uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@rocketvax.com), used 100% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@rocketvax.com	100%

About Rocketvax

The company brings together both scientific and operational expertise from various institutions in Switzerland and Germany and aims to become a world leading centre of excellence for novel vaccine development. RocketVax has its foundation in the ties between Swiss Rockets AG, a Swiss incubator and accelerator for startups with innovative therapies, and a team of expert scientists from the Universities of Basel and Zurich, the ETH Zurich, the University Hospital Basel and the Swiss Tropical and Public Health Institute in Basel, and Gigabases Switzerland AG, a spinoff of ETH Zurich. Starting with the innovative concept of a live, single-cycle vaccine against SARS-CoV-2, Rocketvax’ portfolio was diversified by acquiring a platform encompassing multiple technologies for the generation of live-attenuated vaccines. RocketVax has partnered with a group of Swiss and internationally recognized teams of virologists and biochemists from the Swiss Federal Institute of Virology and Immunology, the Universities of Bern and Geneva, the Freie Universität Berlin and the Federal Institute for Animal Health of Germany, the Friedrich Loeffler Institute. At RocketVax, we use proprietary molecular biology technologies to develop novel vaccines for infectious diseases like Covid-19, cancer, and auto-immune-disorders. Several vaccine candidates in our pipeline are being developed and include the original live, single-cycle virus vaccine as well as live-attenuated vaccines against SARS-CoV-2 and a vaccine candidate against cancer.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Manager

Partner

Employees by Department

Rocketvax has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

Explore Rocketvax's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-09-03	3	$2

Funding Insights

Total funding amount

Most recent funding amount

Number of funding rounds

Rocketvax Tech Stack

Discover the technologies and tools that power Rocketvax's digital infrastructure, from frameworks to analytics platforms.

Google Tag Manager

Tag managers

GoDaddy

Hosting

Node.js

Programming languages

Nginx

Reverse proxies

PWA

Miscellaneous

lit-element

JavaScript libraries

Google Analytics

Analytics

Google Maps

Maps

lit-html

JavaScript libraries

Express

Web frameworks

Microsoft 365

Frequently asked questions

Rocketvax is located in Basel, Basel, CH.

You can reach Rocketvax at +41615615421.

Rocketvax generates an estimated annual revenue of $513,330. This revenue figure reflects the company's market position and business performance in its industry.

Rocketvax has an estimated valuation of $1,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Rocketvax was founded in 2020, making it 6 years old. The company has established itself as a significant player in its industry over this time.

Rocketvax has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Rocketvax has raised a total of $2 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Rocketvax

Vladimir Cmiljanovic

Founder, Vice-Chairman And Ceo Of Rocketvax Ag

4.8

40,000 users